Breaking
iRhythm Technologies

iRhythm Technologies

Remote Patient Monitoring & Wearables

iRhythm is a leading digital health company that creates trusted solutions to detect, predict, and prevent cardiac disease.

About iRhythm Technologies

iRhythm Technologies is a digital health company that provides ambulatory cardiac monitoring services, including AI-assisted ECG analysis for arrhythmia detection.

Mission & Approach

Mission

iRhythm is shaping the future of heart monitoring and empowering better health for all

AI Approach

Deep learning for ECG signal analysis and arrhythmia detection

Products & Solutions

Zio AT

device

Advanced telemetry ECG monitor with real-time transmission capabilities

An advanced ambulatory cardiac telemetry monitor that provides continuous ECG monitoring with transmission capabilities. Does not require battery changes or charging, though it has wear time transmission limits. Contraindicated for critical care patients. Designed for patient comfort and compliance while enabling continuous, uninterrupted cardiac monitoring.

Deploy: embeddedPricing: undisclosedEHR: EHR Integration available

MyZio Patient App

software

Patient-facing mobile app for cardiac monitoring support and engagement

A mobile application that supports patients throughout their cardiac monitoring journey. Features include digital symptom logging, educational content about heart health and arrhythmias, medication reminders, and guidance for using Zio monitors. Designed to improve patient engagement and compliance during the monitoring period.

Deploy: cloud saasPricing: undisclosed

ZioSuite

platform

Comprehensive clinician portal for cardiac monitoring data management and reporting

A cloud-based clinical portal that allows healthcare providers to interpret reports, manage patients, and access cardiac monitoring data from computer or mobile devices. Includes a provider mobile app for on-the-go access. Integrates with EHR systems to simplify data collection and entry, enhance interdisciplinary access, and boost workflow efficiency.

Deploy: cloud saasPricing: undisclosedEHR: EHR Integration available

iRhythm AI Algorithm

model

FDA-cleared deep learning algorithm for automated ECG analysis and arrhythmia detection

The first FDA-cleared, deep-learned AI algorithm for cardiac rhythm analysis, proven to be as accurate as expert cardiologists. Processes over 2 billion hours of curated heartbeat data from more than 12 million patients analyzed. The algorithm generates comprehensive reports verified by Qualified Cardiac Technicians (QCTs), achieving 99% physician agreement with end-of-wear reports.

Deploy: cloud saasPricing: undisclosed

Zio monitor

Flagshipdevice

Advanced ECG patch monitor for continuous cardiac arrhythmia detection

A state-of-the-art, patient-friendly wearable ECG monitor designed for extended continuous cardiac monitoring. The device captures uninterrupted heart rhythm data with near-perfect patient compliance (99%), enabling high diagnostic yield for arrhythmia detection including atrial fibrillation. Features comfortable, easy-to-wear design that patients can use without battery changes or charging requirements.

Deploy: embeddedPricing: undisclosedEHR: EHR Integration available

iRhythm Cardiac Monitoring Service

Flagshipservice

End-to-end cardiac monitoring service combining devices, AI analysis, and clinical reporting

A comprehensive cardiac monitoring solution that integrates Zio ECG monitors, FDA-cleared AI-assisted analysis, expert clinical review by Qualified Cardiac Technicians, and physician-ready actionable reports. The service includes the ZioSuite portal, seamless EHR integration, patient support via MyZio app, and 24/7/365 billing and customer support. Delivers highest diagnostic yield and lowest likelihood of retesting compared to other ambulatory cardiac monitoring services.

Deploy: hybridPricing: undisclosedEHR: EHR Integration available

Customer Success Stories

Commercially insured patient populations (AVALON Study)

payer

Assessment of variation in ambulatory cardiac monitoring strategies examining how monitoring approach influenced arrhythmia diagnosis, clinical outcomes, and healthcare resource utilization

Demonstrated superior diagnostic yield and resource utilization efficiency compared to alternative monitoring strategies
Read case study →

Medicare beneficiaries study

government

Comparative effectiveness study of ambulatory cardiac monitoring strategies in Medicare population to assess diagnostic yield, clinical outcomes, and healthcare utilization

Highest diagnostic yield and lowest likelihood for retest compared to other monitoring services
Read case study →

Over 12 million patients analyzed

other

Real-world deployment of iRhythm cardiac monitoring service across diverse patient populations for arrhythmia detection and diagnosis

99% physician agreement with end-of-wear reports, near-perfect patient compliance, over 2 billion hours of curated heartbeat data
Read case study →

Hiring Activity

View Open Roles →

Product & Market

Product Stage

enterprise

Primary Market

providers

Company Details

Founded
2006
Headquarters
San Francisco, CA, USA
Employees
1001
Stage
public
Profile last updated
June 22, 2026

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Social & Media

Follow on

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.